Description
Viral Infections and Antiviral Therapies provides comprehensive coverage of viral infections and their transmission. Coverage includes antiviral agents, therapeutics, their mechanisms and treatment strategies. The book is organized into four sections, including an introduction to antiviral therapies, viral infections and their transmission, antiviral agents and therapeutics, and a market overview and future developments. The chapters in each section of the book discuss various key topics that are contributed to by an international group of leading experts.- Covers emerging and sexually transmitted viruses, including mode of transmission and pathophysiology of viral infections- Describes antiviral agents and therapeutics for viruses such as rotaviruses, enteroviruses and coronaviruses- Discusses strategies for the delivery of antiviral agents and vaccinations
Table of Contents
Section I: Introduction1. Introduction to antiviral therapySection II: Viral infections and transmission2. Emerging viral diseases3. Evolution and transmission of viruses4. Mode of viral infections and transmissions5. Transmission and Intervention Dynamics of SARS-CoV-26. Sexually transmitted viral infections7. Testing of viral infections8. Electron microscopic methods for virus diagnosisSection III: Antiviral agents and therapeutics9. Virotherapy10. Challenges in designing antiviral agents11. Anti-influenza agents12. Anti-herpes virus agents13. Antiretroviral Therapies14. Rotavirus and anti-rotaviral agents: Trends and advances15. Current therapeutic strategies and novel antiviral compounds for the treatment of non-polio enteroviruses16. Antiviral agents against flaviviruses17. Pathophysiology of HIV and strategies to eliminate AIDS as a public health threat 18. Herbal drugs to combat viruses19. Strategies for delivery of antiviral agents20. Nanovesicles for delivery of antiviral agents21. Antiviral biomaterials22. Antiviral biomolecules from marine inhabitantsBalasubramanian 23. Plant polysaccharides as antiviral agents24. Antiviral peptides against dengue virus25. mRNA vaccines for COVID-1926. Immunotherapy as an emerging and promising tool against viral infections27. Role of nutraceuticals as immunomodulators to combat virusesSection IV: Others28. In vitro and in vivo approaches for evaluating antiviral efficacy29. Clinical trials and regulatory considerations of antiviral agents30. Future perspectives of antiviral therapy
